Risk Stratification of Newly Diagnosed Prostate Cancer with Genomic Platforms

Risk stratification tools incorporating genomic analysis of prostate cancer have been developed which seek to improve the accuracy of initial predictions. Further study is warranted to define the additive clinical benefit associated with their use if implemented broadly.